check_circleStudy Completed
Magnetic Resonance Imaging
Bayer Identifier:
13926
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Observational study on the safety and tolerability of Gadobutrol (Gadovist) among Filipino patients in Magnetic Resonance Imaging
Trial purpose
Patients will be recruited from those who will undergo contrast enhanced MRI. Safety and tolerability will be assessed.
Key Participants Requirements
Sex
BothAge
18 - N/ATrial summary
Enrollment Goal
30Trial Dates
June 2009 - January 2011Phase
N/ACould I Receive a placebo
NoProducts
Gadavist/Gadovist (Gadobutrol, BAY86-4875)Accepts Healthy Volunteer
NoWhere to participate
Status | Institution | Location |
---|---|---|
Completed | Many Locations, Philippines |
Primary Outcome
- The primary outcome measures would be safety and tolerability of Gadovist which would be measured by change in Vital signs before and after the procedure and the occurrence of serious or non-serious adverse eventsdate_rangeTime Frame:Up to 1 hour after MRIenhanced_encryptionYesSafety Issue:
Trial design
Trial Type
ObservationalIntervention Type
DrugTrial Purpose
N/AAllocation
N/ABlinding
N/AAssignment
N/ATrial Arms
N/A